On Wednesday, 14 medications produced by 14 separate companies were deemed "substandard" by the karnataka government's Drug Testing Laboratory. According to an official statement, the state's Food Safety and Drug Administration department has instructed physicians, hospitals, nursing homes, wholesalers, and pharmacists not to keep, sell, or use certain medications and cosmetics.
"They are asked to notify the local Assistant drugs Controller or drugs Inspector if they have any stock. Additionally, the letter cautioned the public against using these medications or cosmetics. The substandard drugs include compound sodium lactate injection IP (Ringer-Lactate solution for injection) manufactured by Ultra Laboratories (batch no: KI124110) and Tam Bran Pharmaceuticals; Pomol-650 (Paracetamol tablets I P 650 mg) by Aban Pharmaceuticals (batch no: 13-4536) and MITO Q7 Syrup by Bion Therapeutics india (batch no: CHS-40170) among others.
To protect the public's health, the agency has advocated strict adherence to these guidelines. In response to this finding, the department has issued strict directives to chemists, wholesalers, doctors, hospitals, and nursing homes, prohibiting them from stocking, selling, or using these identified drugs and cosmetics. An official statement emphasized the urgency of compliance to protect public health, urging all stakeholders to immediately cease any involvement with these products. The department has also called for reporting any existing stocks to the concerned area drugs Inspector or Assistant drugs Controller, facilitating a swift recall and disposal process.
"They are asked to notify the local Assistant drugs Controller or drugs Inspector if they have any stock. Additionally, the letter cautioned the public against using these medications or cosmetics. The substandard drugs include compound sodium lactate injection IP (Ringer-Lactate solution for injection) manufactured by Ultra Laboratories (batch no: KI124110) and Tam Bran Pharmaceuticals; Pomol-650 (Paracetamol tablets I P 650 mg) by Aban Pharmaceuticals (batch no: 13-4536) and MITO Q7 Syrup by Bion Therapeutics india (batch no: CHS-40170) among others.
To protect the public's health, the agency has advocated strict adherence to these guidelines. In response to this finding, the department has issued strict directives to chemists, wholesalers, doctors, hospitals, and nursing homes, prohibiting them from stocking, selling, or using these identified drugs and cosmetics. An official statement emphasized the urgency of compliance to protect public health, urging all stakeholders to immediately cease any involvement with these products. The department has also called for reporting any existing stocks to the concerned area drugs Inspector or Assistant drugs Controller, facilitating a swift recall and disposal process.
click and follow Indiaherald WhatsApp channel